Global assembling of Academicians, Researchers, Scholars & Industry to disseminate and exchange information at 100+ Allied Academics Conferences

Theme
Stem cells: A customized approach for well being
- Stem Cell Congress 2018

About Conference

Allied Academics Publication is an amalgamation of several esteemed academic and scientific associations known for promoting scientific temperament. Established in the year 1997, Andrew John Publishing Group is a specialized Medical publisher that operates in collaboration with the association and societies.  This publishing house has been built on the base of esteemed academic and research institutions including The College of Audiologists and Speech Language Pathologists of Ontario(CASLPO), The Association for Public Safety Communications Officials of Canada (APCO), The Canadian Vascular Access Association (CVAA), The Canadian Society of Internal Medicine (CSIM), The Canadian Hard of Hearing Association (CHHA), Sonography Canada, Canadian Association of Pathologists (CAP-ACP) and The Canadian Association of Neurophysiologic Monitoring (CANM).

Allied Academics invites all the participants from all across the globe to attend "International Conference on Stem Cells and Regenerative Medicine”, on June 4-5, 2018 in Osaka, Japan, which includes prompt keynote presentations, poster presentations, oral talks, and exhibitions.

Stem cells are unique cells with an ability to differentiate in any other cells of the body. Two types of stem cells found in the body, embryonic and somatic, holds enormous therapeutic potential to repair and regenerate damaged tissues. Regenerative medicine is an application of stem cell research which harnesses the potential of tissue engineering to stimulate repair mechanism of body and restore the damaged tissues and organs. Therefore, development of disease specific therapies and treatments by exploiting the remarkable properties of stem cells holds hope for improvement of quality of life and survival of patients with chronic disorders.

Objective:

Stem Cell Congress 2018 is a platform to achieve the prevailing gaps in the transformation of this multi- disciplinary science of hope, to serve promptly with solutions to all in the need. Stem Cell Congress 2018 will have an anticipated participation of 120+ delegates across the world to discuss the purpose of conference.

About Organizers:

Allied Academics is one of the leading Open Access publishers and organizers of international scientific conferences and events every year across USA, Europe & Asia.  Allied Academics  has so far organized 3000+ Global Allied Academics  Events with over 600+ Conferences, 1200+ Symposiums and 1200+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business with 700+ peer-reviewed open access journals in basic science, health, and technology.

Scientific Sessions:

Stem Cell Congress 2018 will encompass recent researches and findings in Stem cell therapies and research, tissue engineering and transplantations, scope and future of regenerative medicine, current understanding of nanotechnology in regenerative medicine, reprogramming of stem cells, advancements in Cancer stem cells research and the possibilities of genome manipulation in stem cell research.

Stem Cell Congress 2018 will be a great platform for research scientists and young researchers to share their current findings in this field of applied science. The major scientific sessions in Stem Cell Congress 2018 will focus on the recent and exciting innovations in prominent areas of tissue engineering technology and stem cells research.

Target Audience:

Eminent personalities, Directors, CEO, President, Vice-president, Research scientists,  Organizations, Post-docs, Associations heads and Professors, Stem Cell laboratory heads, Students and other affiliates related to the area of Stem cells research and regenerative medicine. 

Welcome Message

Stem cell congress 2018 extends a heartiest welcome to proficient delegates, scientists, professors, students, young researchers, business executives, scholars, chemists and professionals across the globe to be a part of 'International conference on stem cells and regenerative medicine", during June 04-05, 2018, to be held at Osaka, Japan. Keynote presentations, exhibitions, oral talks and poster presentations outlines the key attractions of the conference on the theme "Stem cells : A customized approach for well-being.

Allied Academics organizes Stem Cell Congress- 2018 conference along with 300+ Conferences across USA, Europe & Asia every year with support from 1000 more scientific societies and Publishes 400+ Open access journals which contains over 30000 eminent personalities as editorial board members.

We invite you to join us at the Stem Cell Congress- 2018, where you will be sure to have a meaningful experience with scholars from around the world. All members of the Stem Cell Congress- 2018 organizing committee look forward to meeting you in Osaka, Japan.

Sessions & Tracks

Track 1: Stem cells: An insight

Stem cells are undifferentiated cells found in multicellular organisms which divide through mitosis and differentiate into specialized cells. The two classical properties of stem cells which allows them to differentiate into almost any kind of body cell, are, self- renewal and potency. Due to their potential role in alternative therapies, stem cells are a topic of extensive research medical sciences.

·         Collecting human embryonic stem cells

·         Growth factors in stem cell differentiation

·         In-vitro culturing of stem cells

·         Future prospects of somatic stem cells

Track 2: Molecular basis of regeneration

Regeneration is a universal phenomenon in nature by which lost cells, tissues or body parts are replaced or restored in an organism as a general process of growth.  During this process, adult stem cells or progenitor cells proliferate and differentiate to compensate the loss. The ability to regenerate depends upon the potency of any cell, categorized under totipotent, pluripotent, multi- potent, omnipotent and uni-potent.

·         Hematopoietic stem cells for blood disorders

·         Mesenchymal stem cells for neuromuscular disorders

·         Directed differentiation of  somatic stem cells

Track 3: The science of tissue engineering

Tissue engineering is a multi-disciplinary science involving the principles of cell biology, engineering and material sciences to replace or restore biological tissues which perform a specific function with a better framework. It is an act of combining the cells of construct, scaffold and growth factors into a functional tissue. The feasibility of bone-marrow derived mesenchymal stem cells, cardiac valves, auricular cartilage reconstruction, etc. explains the enormous potential of this relatively new field in biomedical sciences.

·         Artificial cardiac valves

·         Extracellular matrix analogues

·         Auricular cartilage reconstruction

·         Biomaterials and biopolymers for tissue engineering

·          Hydrogels for tissue engineering

·         Dermal tissue engineering

Track 4: Concept of tissue regeneration and regenerative medicine

Not all tissues in the body are devised to regenerate after damage. Tissue regeneration emphasises on the science of regenerating functional body parts for medical treatments aimed at restoring normal body functions after disease, trauma and congenital issues. It gives rise to a translational field of regenerative medicine, came into existence two decades ago, and, harnesses the principles of molecular biology and tissue engineering. Use of stem cells is an integral part of regenerative medicine which emphasises on the possibility of culturing tissues and organs in-vitro and their implantation into the subject.

·         Antibiotic based tissue regeneration scaffolds

·         Prevention of intervertebral discs degeneration

·         Ligament regeneration with biomechanics

·         Osteoarthritis and knee joint replacement

·         Artificial pacemakers

·         Organ regeneration and artificial pancreas.

Track 5: Current era of stem cell research

Stem cell research laid a foundation of basic scientific perception about the development of whole organism from a unicellular entity or single cell itself. These cells are collected from few days old embryo, amniotic fluid or many other tissues, like, bone marrow and cultured in the laboratory under biological conditions. Stem cell research is an aid of utmost important to serve as a model for genetic disorders, study DNA repair mechanisms or to design replacement therapies for practically immedicable chronic conditions.

·         Bone marrow transplant for adenosine deaminase deficiency (ADA)

·         Clinical research in stem cell therapy

·         Stem cells in organ development

·         Immune suppression of xenografts

·         Induction of cancer by stem cells

Track 6: Stem cell therapeutics

Stem cell therapy is aimed at treating numerous degenerative, hematopoietic and neuromuscular disorders, nearly 80 in number which cannot be treated with conventional methods. Bone marrow transplantation for blood disorders like, leukaemia is the most celebrated application of stem cell therapy, other than skin tissue grafting and implantation. This new approach in medical biology is inclined at maximizing the quality of life by reducing the adversities of chronic disorders such as cancer and genetic diseases.

·         Myelogenous or lymphocytic leukemia

·         SCID-X1 stem cell therapy

·         Type-I diabetes

·         Alzheimer’s disease

·         Parkinson’s disease

·         Spinal cord trauma  

Track 7: Nano-biotechnology in regenerative medicine

Nano-biotechnology in medical sciences renders some highly convincible outcomes in which few are only envisioned, while others are at different phases of clinical trials or already in practice. Nano-biotechnology in regenerative medicine includes utilization of nano-particles which are being designed now-a-days and envisioned research that involves usage of nano-robots to imply changes at cellular and molecular level. Recently, it is being used for drug-delivery, thermo- and laser therapy for cancer treatment. Particles are designed in such a way that they are easily being recognized by surface receptors of target cells to ensure direct treatment and least possible damage to unaffected cells. This technology is also exploited for detection of diseases in initial phases for devising an effective therapy. 

·         Pharmaceutical nanotechnology

·         Nanoparticle based anti-bacterial scaffolds

·         Nanoparticle based drug-delivery systems

·         Nanotheranostic systems and their applications

·         Nano-robots in therapy

·         Nanoparticle imaging for disease diagnosis

Track 8: Bio-informatics in stem cell research

Bio-informatics deals with the development of algorithms and databases to manage, predict and analyse biological data. In-silico analysis of small molecules as a potential drug delivery target is a preliminary step in drug designing to ensure maximum efficacy. Self- learning algorithms, like, artificial neural network, are important tool for vaccine designing. Computational biology along with bio-informatics is a vast domain incorporating consolidated facts from computer science engineering, animation, ecology, genomics, immunology, neuroscience, biochemistry and biophysics which can be used as pre-knowledge tools for designing stem cell therapies.

·         In-silico vaccine designing

·         Molecular docking for drug delivery

·         Designing therapies for genetic disorders

Track 9: Cancer stem cells

Certain immortal cells within the tumour are capable of proliferating into all other types of cancer cells. These cells, known as cancer stem cells, are the primary targets of cancer biologist and oncologist for treatment of various tumours, even though they are fairly resistant to chemotherapy and radiotherapy. Approaches have been made to exploit the property of these cells to develop immortal cell lines for production of drugs and cytokines relevant to medical use, but, a lot more understanding is required before bringing the results in practice.

·         Prognostic and diagnostic biomarkers of cancer stem cells

·         Targeting tumorigenic cells

·         Pharmaceutical applications of cancer stem cells

·         CSC drug resistance

·         Cancer antigens as immunotherapy targets

Track 10: Reprograming of stem cells

The discovery of Induced pluripotent stem cells emphasises on reprograming of any adult differentiated cells into stem cells by genetic modification under precisely controlled laboratory conditions. Reprograming of cells is supposed to presage revolution in both, medical and biological research and allows modelling and analysis of human diseases and cell cytotoxicity by drugs. The technique is still in its growing phase and requires a great deal of extensive research and approval from authorities for further trials.

·         Induced pluripotent stem cells

·         Disease modelling using iPSC for Muscular Dystrophy

·         Regeneration of RBCs

·         Wiskott-Aldrich syndrome

Track 11: Stem cell banking

Umbilical cord blood is highly enriched with pluripotent stem cells which are considered lifesaving in later stages of life as they can treat a host of disorders. Cord blood stem cells are used to target blood disorders, immune deficiencies and rare metabolic disorders, including leukaemia, Krabbe disease, aplastic anaemia, non-Hodgkin’s lymphoma and Hodgkin’s lymphoma, sickle-cell anaemia and thalassemia, with least chances of rejection by the body. Cord blood preservation of new born babies, also termed as, stem cell banking, in public or family banks, is gaining a lot of awareness among people as it holds promise for future well-being.

·         Global market of cord blood preservation

·         Clinical aspects of stem cell banking

Track 12: Genome editing in stem cells

The development of targeted genome editing technique using custom-engineered sequence-specific nucleases (including CRISPR/Cas9) allowed genetic changes with greater precision. This technique has a widespread application in reprograming of stem cells to study disease outcomes. The rapid evolution of these two techniques over years and their relationship with one another has paved a way for understanding cellular interactions and regulation of transcription at molecular level with appreciable efficiency and flexibility.

·         CRISPR/Cas9 in genome editing

·         Genome editing for designer babies

·         DNA repair in stem cells

·         Generation of animal models by genome editing

·         Targeting genetic diseases by genome editing in stem cells

Track 13: Future prospects of stem cell research and regenerative medicine

The extent of research in the field of stem cells has grown manifolds over the past few decades. Use of adult stem cells in alternate disease therapies is the new promising approach with striking progress in regenerative medicine. With the emergence of new stem cell pharmaceutical products for disease control, therapeutic potential of stem cells and tissue regeneration seems boundless.

·         Vision improvement

·         Tooth regeneration

·         Gene therapy for blood transfusion

·         Bone regeneration

·         Skin rejuvenation

Track 14: Bioethical issues and challenges in stem cell research

Stem cells and their applications in tissue regeneration comes with a few interesting controversies regarding the bioethical issues involved in stem cell research. The collection of somatic stem cells from the human foetuses and umbilical cords is the most extreme controversy so far. Other issues involves the potential of stem cells to induce a tumour in the body and use of embryos which are only few days old. Human embryo cloning was suggested as an alternative to this situation which was highly criticized by the ethical groups. Currently, lack of stem-cell markers and in-vitro systems for manipulation, also hinders the research and makes it a daunting task.

Market Analysis

Importance and Scope

“Cell Science and Stem Cell Research and Regenerative Medicine ” was important is due to human development is only from stem cells. As such, an understanding of their unique attributes and control can teach us more about early human development. Diseases such as cancer are thought to result from abnormal cell proliferation and differentiation. This means that an understanding of where things go 'wrong' in stem cell division and thus lead to cancer can help us find ways to prevent the dysfunctional changes or employ effective ways to treat them with targeted drugs. Stem cells are a type of human cells that give rise to the various types of cells found in the human body. Stem cells hold the potential to evolve into various types of human tissue, which has led to a growing acknowledgement of the obvious medical potential of this property. Stem cell therapy is becoming increasingly common in the treatment of various diseases and the increasing research in the field is expected to further drive the medical applications of stem cells in the coming years.

Why Atlanta ?

There are many reasons why you should visit this amazing country. Atlanta finished 2016 with its strongest quarter of the year absorbing just over 1 million business space, bringing the total to 1.5 million. On the whole, not necessarily a bad year of occupancy gain; however, when compared to last year, 2016’s business is down roughly 65%. Atlanta is a country of a rich and ancient history, strikingly beautiful landscape and proud, hardy people. Atlanta's 343 parks, nature jam, and gardens cover. During September toNovember  month the scenery changes color and are a fantastic time for outdoor activities, it is a particularly good time for people interested in Photography, Atlanta will offer you a great time and a warm welcome, November  is the best time to visit the Atlanta USA. Atlanta the host city, is among the most exquisite tourist destination, and hence the perfect place to hold such event.

Market Value

Cell Science currently it has emerged as a rapidly diversifying field with the potential to address the worldwide organ shortage issue and comprises of tissue regeneration and organ replacement. The global tissue engineering and regeneration market is expected to grow to nearly $20.8 billion in 2014 and $56.9 billion in 2019, a compound annual growth rate (CAGR) of 22.3%.

The global stem cell therapy market over the forecast period of 2015 to 2020.The market is poised to grow at a CAGR of 39.5% from 2012 to 2018, to reach $330 million by 2020
    
The global stem cell therapy market over the forecast period of 2015 to 2020.The market is poised to grow at a CAGR of 39.5%from 2015 to 2020, to reach $330million by 2020.

Global Regenerative Medicines Market Overview

Global Regenerative medicines market is projected to reach $ 30,237 million by 2022. Cell therapy segment is expected to dominate the market throughout the forecast period. North America led the global market in 2015, and is expected to remain dominant during the 2015-2022. Global stem cell therapy market is growing at a CAGR of 39.5% from 2015 to 2020, to reach $330 million by 2020.

The global cell sorting market is projected to reach USD 247.4 Million by 2021, at a CAGR of 7.0% Factors such as technological advancements in rising funding and investments for development of technologically advanced cell sorters, and growing adoption of cell sorting techniques in research activities are driving the growth of this market. The market is further driven by factors such as the growing prevalence of HIV/AIDS and cancer, expanding pharmaceutical and biotechnology industries, and launch of specific reagents for specific applications.

The major factors boosting the market growth include technological advancements in tissue and organ regeneration, increasing prevalence of chronic diseases and trauma emergencies, prominent potential of nanotechnology, and emergence of stem cell technology. In addition, increasing incidence of degenerative diseases and shortage of organs for transplantation are expected to boost the growth of the market. The prominent potential of regenerative medicine to replace, repair, and regenerate damaged tissues and organs has boosted the market growth. Moreover, utilization of nanomaterials in wound care, drug delivery, and immunomodulation has opened growth avenues for the regenerative medicines market. However, stringent regulatory barriers and high cost of the treatment are likely to hinder the market growth.
                                                                  

What are Some of the Major Drivers for the Stem Cells Market ?

The key driver for the global stem cells market is the increasing government support across the world. As widespread incorporation of stem cell therapy allows a nation to significantly improve the overall healthcare scenario, countries in North America and Western Europe have provided solid support to stem cell research. The acceptance of stem cell therapy in developing countries is still lagging behind due to the lack of advanced medical infrastructure and funds, but the steady improvement of the healthcare sector in countries such as India and China is likely to be a major growth driver for the global stem cells market. The increasing prevalence of neuro degenerative disorders is another major driver for this global demand. Neural tissue can’t be regenerated or replaced as easily as structural tissues, and the ability of stem cells to develop into human cells provides the perfect avenue for treatment of neuro degenerative conditions.

Stem cell Market Segmentation and Industry Structure 

Stem cells are widely used in drug discovery and medicine and in regenerative medicine. In 2016, approximately 90% of the revenue was generated from regenerative medicine owing to the large usage of them in treatment of Parkinson’s and Huntington’s. Stem cell research was segmented into Basic research and therapeutic research in which allogenic cell therapy succeeded 100% according to the global market of stem cells.

Venue
&
Hospitality


Join The Discussion

Quick Links

Contact Desk

Program enquiry

Hazel Brown

stemcellcongress18@gmail.com

+44 800 086 8979

Sponsorship oportunity

Hazel Brown

stemcellcongress18@gmail.com

+44 800 086 8979

General enquiry

Hazel Brown

stemcellcongress18@gmail.com

+1 800-858-2189

Special Issues
All accepted abstracts will be published in respective Allied Academies Journals.
Abstracts will be provided with Digital Object Identifier by

Mail us at

Program enquiry
stemcellcongress18@gmail.com
Sponsorship oportunity
stemcellcongress18@gmail.com
General enquiry
stemcellcongress18@gmail.com
More details about sponsorship:sponsors@alliedacademies.com

Highlights from last year's Convention

Copyright © 2017-2018 Allied Academies, All Rights Reserved.